The May 31 BMJ focused on the relationship between physicians and drug companies. One of the aspects of this relationship reviewed was the frequency of pharmaceutical company rep visits to physicians. How do you think weekly visits from a pharmaceutical company rep affect physicians' prescribing habits of that company's drugs?
